Mihashi Satoko, Ishida Yukisato, Watanabe Masaru
Department of Frontier Health Sciences, Graduate School of Human Health Sciences, Tokyo Metropolitan University, 7-2-10 Higashiogu, Arakawa-ku, Tokyo 116-8551, Japan.
J Smooth Muscle Res. 2020;56(0):19-28. doi: 10.1540/jsmr.56.19.
Blebbistatin, a potent inhibitor of myosin II, is known to suppress smooth muscle contraction without affecting myosin light chain phosphorylation level. In order to clarify the regulatory mechanisms of blebbistatin on phasic and tonic smooth muscles in detail, we examined the effects of blebbistatin on relaxation process by Ca removal after Ca-induced contraction of β-escin skinned (cell membrane permeabilized) trachea and taenia cecum preparations from guinea pigs. Blebbistatin significantly suppressed the force during relaxation both in skinned trachea and taenia cecum. The data fitting analysis of the relaxation processes indicates that blebbistatin accelerates slow (latch-like) bridge dissociation.
肌球蛋白 II 的强效抑制剂 blebbistatin 已知可抑制平滑肌收缩,而不影响肌球蛋白轻链磷酸化水平。为了详细阐明 blebbistatin 对相性和紧张性平滑肌的调节机制,我们研究了 blebbistatin 对豚鼠β-七叶皂苷透皮(细胞膜通透化)气管和盲肠带绦虫制剂在钙诱导收缩后通过去除钙来进行的舒张过程的影响。Blebbistatin 显著抑制了透皮气管和盲肠带绦虫在舒张过程中的张力。舒张过程的数据拟合分析表明,blebbistatin 加速了缓慢(闩锁样)桥解离。